Here are the S-1 registration statements from Antiaging Qntum LGN A (AAQL) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-1 covers the registration statement a company files to sell shares publicly, so if you follow AAQL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AAQL filings page.
Antiaging Quantum Living Inc. has filed an S-1 to register up to 4,280,342 shares of its Class A Common Stock for resale by existing selling stockholders. These shares were issued upon automatic conversion of amended promissory notes at a fixed price of $0.30 per share, so no new shares are being created by this registration. The company will not receive any proceeds from the resale of these shares; any cash raised will go to the selling stockholders.
After the note conversions, the company reports 34,275,342 shares of Common Stock issued and outstanding, unchanged by the resale. Antiaging Quantum Living operates a small U.S. online advertising platform and higher-growth technical service and non-medical health-management businesses in China under its Dao Ling Doctor subsidiaries, but notes ongoing net losses, shareholder deficit, heavy reliance on a single key executive, the need for additional capital, penny-stock trading status on the OTC Pink under symbol AAQL, and significant competition and operational risks in both the U.S. and PRC markets.